Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio
FARALLON CAPITAL MANAGEMENT LLC Performance:
2025 Q3: 3.45%YTD: 6.74%2024: 17.04%
Performance for 2025 Q3 is 3.45%, and YTD is 6.74%, and 2024 is 17.04%.
About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in SAN FRANCISCO, CA. On 20-Jul-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $41.2 Billions. In it's latest 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $24.4 Billions as of 30 Sep, 2025.
The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are MSFT, AON, EXEL. The fund has invested 4.1% of it's portfolio in MICROSOFT CORP and 3.3% of portfolio in AON PLC.
The fund managers got completely rid off HESS CORP (HES), LIBERTY BROADBAND CORP (LBRDA) and ANSYS INC (ANSS) stocks. They significantly reduced their stock positions in GE HEALTHCARE TECHNOLOGIES I, ULTRAGENYX PHARMACEUTICAL IN (RARE) and GENEDX HOLDINGS CORP (SMFR). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in KELLANOVA (K), ISHARES ETHEREUM TR and NORFOLK SOUTHN CORP (NSC). The fund showed a lot of confidence in some stocks as they added substantially to NOVAVAX INC (NVAX), UNIQURE NV (QURE) and SOLENO THERAPEUTICS INC (SLNO).
The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are MSFT, AON, EXEL. The fund has invested 4.1% of it's portfolio in MICROSOFT CORP and 3.3% of portfolio in AON PLC.
The fund managers got completely rid off HESS CORP (HES), LIBERTY BROADBAND CORP (LBRDA) and ANSYS INC (ANSS) stocks. They significantly reduced their stock positions in GE HEALTHCARE TECHNOLOGIES I, ULTRAGENYX PHARMACEUTICAL IN (RARE) and GENEDX HOLDINGS CORP (SMFR). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in KELLANOVA (K), ISHARES ETHEREUM TR and NORFOLK SOUTHN CORP (NSC). The fund showed a lot of confidence in some stocks as they added substantially to NOVAVAX INC (NVAX), UNIQURE NV (QURE) and SOLENO THERAPEUTICS INC (SLNO).
FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of 3.45% in the last quarter. In trailing 12 months, it's portfolio return was 7.65%.
New Buys
| Ticker | $ Bought |
|---|---|
| kellanova | 323,475,000 |
| ishares ethereum tr | 234,772,000 |
| norfolk southn corp | 184,752,000 |
| teva pharmaceutical inds ltd | 100,939,000 |
| abivax sa | 68,344,500 |
| mineralys therapeutics inc | 63,442,200 |
| grayscale coindesk crypto | 47,581,700 |
| nektar therapeutics | 45,007,900 |
New stocks bought by FARALLON CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| novavax inc | 4,775 |
| uniqure nv | 3,935 |
| soleno therapeutics inc | 2,960 |
| prime medicine inc | 533 |
| mara holdings inc | 338 |
| grail inc | 168 |
| cidara therapeutics inc | 154 |
| oscar health inc | 146 |
Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| ge healthcare technologies i | -99.77 |
| ultragenyx pharmaceutical in | -99.22 |
| genedx holdings corp | -98.47 |
| healthequity inc | -98.44 |
| globus med inc | -98.1 |
| nuvalent inc | -98.00 |
| alkermes plc | -96.99 |
| iqvia hldgs inc | -75.63 |
FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| jd.com inc | -41,822,000 |
| hess corp | -804,225,000 |
| liberty broadband corp | -420,520,000 |
| championx corporation | -105,446,000 |
| verve therapeutics inc | -40,562,800 |
| azek co inc | -170,735,000 |
| verona pharma plc | -171,190,000 |
| full truck alliance co ltd | -18,312,600 |
FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
FARALLON CAPITAL MANAGEMENT LLC has about 40.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 40.2 |
| Technology | 15.6 |
| Financial Services | 10.6 |
| Industrials | 8.6 |
| Others | 7.3 |
| Communication Services | 6.5 |
| Consumer Defensive | 5.3 |
| Consumer Cyclical | 4.3 |
| Real Estate | 1.4 |
Market Cap. Distribution
FARALLON CAPITAL MANAGEMENT LLC has about 61.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 37.4 |
| MID-CAP | 27.9 |
| MEGA-CAP | 23.8 |
| UNALLOCATED | 7.3 |
| SMALL-CAP | 2.7 |
Stocks belong to which Index?
About 74.4% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 54 |
| Others | 25.6 |
| RUSSELL 2000 | 20.4 |
FARALLON CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC
FARALLON CAPITAL MANAGEMENT LLC has 138 stocks in it's portfolio. About 29.5% of the portfolio is in top 10 stocks. LNTH proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABC | cencora inc | 0.00 | 1,000 | 312,530 | unchanged | 0.00 | ||
| ABT | abbott labs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACLX | arcellx inc | 0.00 | 4,000 | 328,400 | unchanged | 0.00 | ||
| ADI | analog devices inc | 1.31 | 1,299,500 | 319,287,000 | added | 2.15 | ||
| ADSK | autodesk inc | 2.16 | 1,662,850 | 528,238,000 | reduced | -4.69 | ||
| AGIO | agios pharmaceuticals inc | 0.95 | 5,781,070 | 232,052,000 | added | 0.24 | ||
| AKRO | akero therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALE | allete inc | 0.02 | 75,000 | 4,980,000 | new | |||
| ALKS | alkermes plc | 0.00 | 20,800 | 624,000 | reduced | -96.99 | ||
| ALT | altimmune inc | 0.00 | 27,600 | 104,052 | unchanged | 0.00 | ||
| AMED | amedisys inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMZN | amazon com inc | 3.15 | 3,505,700 | 769,747,000 | added | 15.52 | ||
| ANSS | ansys inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AON | aon plc | 3.33 | 2,278,020 | 812,295,000 | added | 14.68 | ||
| ARDX | ardelyx inc | 0.00 | 23,000 | 126,730 | unchanged | 0.00 | ||
| ARMK | aramark | 1.41 | 8,996,200 | 345,454,000 | reduced | -30.26 | ||
| ARQT | arcutis biotherapeutics inc | 0.00 | 26,000 | 490,100 | unchanged | 0.00 | ||
| ARWR | arrowhead pharmaceuticals in | 0.00 | 15,800 | 544,942 | unchanged | 0.00 | ||
| ASMB | assembly biosciences inc | 0.13 | 1,227,590 | 31,426,300 | new | |||
| AXSM | axsome therapeutics inc | 0.00 | 4,000 | 485,800 | unchanged | 0.00 | ||